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a b s t r a c t
Abnormal levels of High temperature requirement A1 (HtrA1) protein have been repeatedly observed in
sera and placentas of preeclampsia patients. To understand the functions of HtrA1 in placentation and in
the etiology of preeclampsia, we established HtrA1/ mice. HtrA1/ mice show intrauterine growth
retardation, and their placentas are small due to a reduced size of the junctional zone and aberrant
vascularization in the labyrinth at the mid-gestation stage. HtrA1 is expressed by Tpbpa-positive
trophoblast precursors in the outer ectoplacental cone and junctional zone from embryonic day 7.5 to
10.5. In the HtrA1/ placenta, Tpbpa-positive cell precursors are decreased in the early stage.
Spongiotrophoblasts and glycogen trophoblast cells, both of which differentiate from Tpbpa-positive
precursors, are consequently decreased in the junctional zone. Fewer spiral artery-associated tropho-
blast giant cells, another cell type derived from Tpbpa-positive precursors, invade the decidua and
associate with maternal arteries in the HtrA1/ placenta than in the wild type placenta. Maternal
arteries in the HtrA1/ decidua have narrower lumens, thicker arterial walls, and more vascular smooth
muscle cells remaining in the walls than those in the wild type decidua, indicating impaired remodeling
of maternal arteries. These results indicate that HtrA1 plays important roles in the differentiation of
trophoblasts from Tpbpa-positive precursors in the ectoplacental cone. Insufﬁcient levels of HtrA1 cause
poor placental development and intrauterine growth retardation, due to aberrant trophoblast differ-
entiation and consequent defects in maternal artery remodeling, and may contribute to the onset of
preeclampsia.
& 2014 Elsevier Inc. All rights reserved.
Introduction
High Temperature Requirement A (HtrA) is a serine protease
family that is highly conserved from bacteria to humans. The key
feature of this family is the combination of a catalytic serine
protease domain with one or more C-terminal PDZ domains
(Clausen et al., 2002). Mammals have four HtrA proteins. HtrA2
is distinct from other three: it is localized in the mitochondria,
involved in quality control of proteins, and related to the patho-
genesis of Parkinson's disease (Strauss et al., 2005). HtrA1, 3 and
4 have similar domain structures which include a secretory signal
sequence, an IGFBP domain and a Kazal-type protease inhibitor
domain in the N-terminal region. Although the physiological
function of HtrA1 remains unclear, human HtrA1 has been linked
with the pathogenesis of osteoarthritis (Hu et al., 1998), rheuma-
toid arthritis (Grau et al., 2006), CARASIL (cerebral autosomal
recessive arteriopathy with subcortical infarcts and leukoencepha-
lopathy)(Hara et al., 2009), age-related macular degeneration
(Dewan et al., 2006; Yang et al., 2006) and cancers (Baldi et al.,
2002; Chien et al., 2004; Mullany et al., 2011). HtrA1 digests
several extracellular matrix proteins such as decorin, biglycan,
ﬁbronectin, ﬁbromodulin and collagens (Tsuchiya et al., 2005;
Grau et al., 2006). HtrA1 inhibits TGF-β signaling in a protease
activity-dependent manner (Oka et al., 2004; Hara et al., 2009).
Although several mechanisms underlying this inhibitory activity
have been suggested (Launay et al., 2008; Shiga et al., 2011;
Graham et al., 2013), the precise mechanism is not yet understood.
HtrA1 is expressed most abundantly in the placenta and its
expression is developmentally regulated (Nie et al., 2003; Oka
et al., 2004; Nie et al., 2005). Abnormal elevation of HtrA1 has
been repeatedly observed in the serum (Inagaki et al., 2012;
Marzioni et al., 2012; Zong et al., 2013) and placenta (Inagaki
et al., 2012) of patients with preeclampsia (PE), a pregnancy-
associated multisystem disorder that is clinically diagnosed by
hypertension and proteinuria (Steegers et al., 2010). In contrast, it
has also been reported that total HtrA1 level decreases in the PE
placenta with intrauterine growth restriction (Lorenzi et al., 2009;
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Zong et al., 2013). These observations suggest that HtrA1 con-
tributes to the normal development of the placenta and to the
pathogenesis of PE. PE affects 2–8% of human pregnancies and
accounts for 9–26% of pregnancy-related mortality worldwide
(Khan et al., 2006; Duley, 2009). Although the pathogenesis of
PE has not been fully elucidated, inadequate development and/or
function of the placenta in early pregnancy may be the key cause
of PE (Redman and Sargent, 2005; Steegers et al., 2010). Speciﬁ-
cally, defective trophoblast invasion and subsequent inadequate
maternal spiral artery remodeling are considered to be the ﬁrst
steps in the development of PE. During normal placentation, fetal
cytotrophoblasts invade into the maternal decidua and align with
uterine spiral arteries. The invading trophoblasts remodel mater-
nal arteries by replacing the maternal endothelium and promote
loss of smooth muscle cells, which results in artery dilation and an
increase in blood ﬂow. Impairment of maternal artery remodeling
leads to placental ischemia and hypoxia. Uneven blood ﬂow to
portions of the placenta causes an ischemic-reperfusion insult and
produces oxidative stress (Redman and Sargent, 2005).
Although the architecture of the mouse placenta is different
from that of the human placenta in several respects (Rossant and
Cross, 2001; McCarthy et al., 2011), the mouse placenta is con-
sidered as a good model to understand human placental develop-
ment and disease. The placenta exerts its various roles through
differentiated trophoblast cell lineages. In mouse, primary parietal
trophoblast giant cells (P-TGCs) are the ﬁrst cells to differentiate
from the mural trophoectoderm after implantation (Simmons and
Cross, 2005; Hu and Cross, 2010). At a later stage, the ectoplacental
cone (EPC), which is derived from the polar trophoectoderm, gives
rise to all the remaining trophoblast cell types of the placenta.
Among these, spongiotrophoblasts (SpTs) and their derivatives,
glycogen trophoblast cells (GlyTCs), are the major cell components
of the junctional zone. The EPC also generates four subtypes of
trophoblast giant cells (TGCs). Spiral artery-associated trophoblast
giant cells (SpA-TGCs), which are analogs of invasive extravillous
trophoblasts (EVTs) in human, invade into the maternal decidua,
and remodel maternal arteries (Adamson et al., 2002; Hu and
Cross, 2010, 2011). The other three TGC subtypes show distinct
functions, unique gene expression patterns and different locations
within the placenta (Simmons and Cross, 2005; Simmons et al.,
2007): secondary parietal TGCs (P-TGCs) line the boundary
between the fetal and maternal placentas and are in direct contact
with maternal blood; canal-associated TGCs (C-TGCs) regulate
maternal vasculature and physiology; and sinusoidal TGCs (S-
TGCs) are located within the sinusoidal spaces of the labyrinth
and modulate growth factors and hormones.
To understand the function of HtrA1 in normal development of
the placenta and its involvement in the etiology of PE, we
generated HtrA1 gene knockout mice. HtrA1-/- mice showed
developmental defects including a small placenta and intrauterine
growth retardation, which were attributed to reductions in the
number of SpTs and GlyTCs in the junctional zone and in the
number of SpA-TGCs invading into maternal spiral arteries. These
abnormalities originate from defects in cell fate determination and
differentiation of trophoblast precursors in the EPC.
Materials and methods
Mice
HtrA1 / mice were produced (Tsuchiya et al., 2005) by the
conventional homologous recombination method using RF8
embryonic stem cells derived from 129/TerSV mice (Meiner
et al., 1996). The structure of the targeting vector, the method of
PCR genotying and the preliminary characterization of HtrA1 /
mice were described previously (Supplementary data in Jones et al.,
2011). The absence of HtrA1 mRNA and protein in the knockout
mice was conﬁrmed (Fig. S1; see also Supplementary data in Jones
et al., 2011). Mice used in this study were initially bred on a mixed
129/Sv and C56BL/6 background. The strain was subsequently back-
crossed into BALB/c background more than 10 generations. Unless
otherwise indicated, the mice used in this study had a mixed 129/Sv
and C56BL/6 background. Data presented in Fig. 1B and some in
supplementary data are results of experiments done on mice back-
crossed to the BALB/c background. Pairs of HtrA1þ /þ or HtrA1 /
mice were mated to obtain placentas, embryos and pups of HtrA1þ /
þor HtrA1 / genotype, respectively. Noon on the day of the
appearance of the vaginal plug was set as embryonic day 0.5
(E0.5). All animal experiments were approved by the animal welfare
sub-committee of Nara Institute of Science and Technology.
Histology
Pregnant mice were sacriﬁced by an overdose of pentobarbital
and perfused with 4% paraformaldehyde (PFA) in phosphate-
buffered saline (PBS) at E9.5, E10.5, E12.5, E14.5 and E16.5.
Placentas were dissected and ﬁxed with 4% PFA/PBS overnight at
4 1C and thenwashed with PBS. For parafﬁn blocks, washed tissues
were dehydrated through a graded ethanol series and xylene, and
embedded in parafﬁn wax. Parafﬁn sections (5-mm thick) were de-
waxed in xylene, rehydrated in an ethanol series, and subjected to
hematoxylin and eosin (HE) or periodic acid Schiff (PAS) staining
according to standard protocols. To prepare frozen tissue blocks,
the washed tissues were incubated in 30% sucrose/PBS overnight.
They were then embedded in OCT compound (Sakura, Tokyo,
Japan), frozen in liquid nitrogen, and stored at 80 1C until use.
For in situ hybridization analysis, 12-mm-thick sections were
prepared. In all experiments, the central parts of the placentas
were analyzed. At least ﬁve wild type or HtrA1 / placentas were
examined for each embryonic day.
In situ hybridization
The HtrA1 probe (Oka et al., 2004) and HtrA3 probe (Tocharus et
al., 2004) were prepared as described. Probes for Tpbpa (Carney et
al., 1993) and Mash-2 (Guillemot and Joyner, 1993) were kind gifts
from Dr. James Cross, as were those for Pl1, Pl2 and Plf (Simmons et
al., 2007) from Dr. David Simmons. Linearized plasmids were used
as templates for preparing digoxigenin (DIG)-labeled RNA probes
using a DIG-RNA labeling kit (Roche, Mannheim, Germany). In situ
hybridization was performed as described (Tocharus et al., 2004)
with some modiﬁcations. Brieﬂy, de-waxed and rehydrated paraf-
ﬁn sections (12 μm thick) or frozen sections (12 μm thick) were
ﬁxed with 4% PFA/PBS, treated with 1 mg/ml proteinase K (Takara,
Otsu, Japan) at 37 1C for 30 min, acetylated for 10 min in 0.25%
(v/v) acetic anhydride (Wako Chemicals, Osaka, Japan), and
hybridized with DIG-labeled probes overnight at 55 1C. Next, the
sections were washed, blocked with a blocking solution (0.5%
Block Ace (Dai Nippon Sumitomo Pharma, Osaka, Japan) and
20% goat serum (Sigma-Aldrich, St Louis, USA) in Tris-buffered
saline (TBS)) for 1 h at room temperature, and then incubated
with alkaline phosphatase-conjugated anti-DIG antibody (Roche)
diluted (1/1000) in blocking solution overnight at 4 1C. The
sections were washed and color was developed using NBT/BCIP.
Immunohistochemistry
Parafﬁn sections were de-waxed and then boiled for 30 min to
retrieve antigens either in citrate buffer (pH 6.0) for isolectin B4 or
in Immuno-active (pH 9.0, Matsunami, Osaka, Japan) for smooth
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muscle α-actin. For isolectin B4 staining, the sections were blocked
in 0.5% Block Ace in TBS for 30 min at room temperature and
incubated with biotin-labeled isolectin B4 antibody (1/100, Vector
Laboratories, Burlingame CA, USA) in PBS overnight at 4 1C.
Subsequently, the sections were incubated with horseradish
peroxidase-conjugated streptavidin (1/100, KPL, Gaithersburg
MD, USA) in PBS containing 0.05% Tween 20 for 1 h at room
temperature and then subjected to DAB development. For smooth
muscle α-actin staining, the sections were blocked in 10% goat
serum in PBS and incubated with rabbit polyclonal anti-smooth
muscle α-actin antibody (1/500, Abcam, Cambridge, UK) in 1%
bovine serum albumin/PBS overnight at 4 1C. They were then
incubated with biotin-conjugated anti-rabbit IgG (1/200, Vector
Laboratories) in 10% goat serum in PBS for 1 h at room tempera-
ture, incubated with the horseradish peroxidase-conjugated strep-
tavidin for 1 h at room temperature, and ﬁnally subjected to DAB
development.
Histomorphometric measurements and statistical analysis
Three sections per placenta at 100-μm intervals from the central
region near the site of umbilical cord attachment were analyzed.
The area and diameter were measured using ImageJ software.
Statistical signiﬁcance was calculated by unpaired Student's
t-test or Welch's t-test. The threshold of signiﬁcance was set at
Po0.05.
Results
Deletion of HtrA1 results in intrauterine growth retardation
HtrA1 / mice were viable and fertile. HtrA1þ /þ , HtrA1þ / ,
and HtrA1 / pups were born in the expected Mendelian ratio
from mating of HtrA1þ / parents. Litter size was not affected by
parental genotype (Fig. 1A and Fig. S2). However, HtrA1/ mice
were signiﬁcantly smaller than wild type mice (Fig. 1B). Parents of
homozygous HtrA1 / mice were mated and the body weights of
the progeny were examined every week after birth. Even in the
HtrA1 / newborn pups were signiﬁcantly lighter than HtrA1þ /þ
mice until the third week, the difference in body weight became
non-signiﬁcant in the fourth week (Fig. 1B). This difference in body
weight in early life suggests that HtrA1 deﬁciency affects placental
or embryonic development. Indeed, when embryos and placentas
were separately weighed at E14.5, both were signiﬁcantly lighter
in HtrA1/ mice than in wild type mice (Fig. 1C).
Placental development is defective in HtrA1 / mice
We suspected that defects in the placenta were responsible for
the smaller embryos and pups of HtrA1 / mice. Next, therefore,
we examined placenta sections histologically. HtrA1/ placentas
showed normal architecture, including three compartments
(decidua basalis, junctional zone and labyrinth); however, they
were smaller than wild type placentas at E12.5 (Fig. 2A and B). We
measured the areas of the total placenta, junctional zone and
labyrinth (Fig. 2S). At E12.5, the total area of HtrA1 / placentas
was signiﬁcantly smaller than that of wild type placentas (Fig. 2S,
top panel).
At E14.5, the phenotype became more prominent (Fig. 2C and
D) and all three areas of the placenta were signiﬁcantly reduced
(Fig. 2S, middle panel). Parafﬁn sections of the placentas were
stained with PAS (Fig. 2E and F). PAS stains GlyTCs, most of which
usually reside in the junctional zone while some invade into the
maternal decidua at E14.5. PAS staining showed the boundary
between the junctional zone and labyrinth more clearly than HE
staining, and hence the reduction of both areas in HtrA1 /
placentas (Fig. 2E and F). Next, we examined the cellular
Fig. 1. Placentas, embryos and pups are small in HtrA1 / mice. (A) Average number of
pups born from crossing of HtrA1þ /þ , HtrA1þ / and HtrA1/ parents. Pairs of HtrA1þ /
þ , HtrA1þ / or HtrA1/ mice were mated (each n¼11) and the number of pups born
was counted. (B) Body weight of wild type (HtrA þ /þ) (n¼10) and HtrA1/ (n¼8)
pups after birth. Mice with the BALB/c background were used. (C) Weight of placentas
and embryos from HtrA1þ /þ (n¼8) and HtrA1  / (n¼7) mice at E14.5. P values were
calculated by Welch's t-test. **¼Po0.01. The boxes indicate the 25th and 75th
percentile, the bands within these boxes indicate median values, and the ends of bars
indicate the maximum and minimum values.
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components of the junctional zone. The junctional zone is mainly
composed of SpTs and GlyTCs at E14.5. SpTs are not stained with
PAS and appear gray in the cytoplasm with large nuclei, while
GlyTCs are stained magenta with small and dense nuclei and
vacuoles in the cytoplasm (Fig. 2K and L). The area occupied by
either SpTs (Fig. 2T, top) or GlyTCs (middle) in the junctional zone
was decreased in HtrA1-/- placentas. There were clusters of PAS-
positive cells in the labyrinth (Fig. 2E and F). These PAS-positive
islands were larger and more numerous in HtrA1-/- placentas than
in wild type placentas (Fig. 2E and F). Higher magniﬁcation
showed that the islands contained PAS-positive GlyTCs and
a small number of PAS-negative SpT-like cells (Fig. 2G and I).
The total area of the PAS-positive islands in the labyrinth was
quantitated (Fig. 2T, bottom), revealing that the placentas of
HtrA1-/- mice had more PAS-positive cells in the labyrinth. In the
normal placenta, a small number of GlyTGs are left behind in the
labyrinth at E14.5. The increased and persistent mislocalization of
PAS-positive trophoblasts in the labyrinth observed in HtrA1-/-
placentas indicates defective differentiation of trophoblasts.
PAS stains the basement membrane of blood vessels, and the
structures of blood vessels were clearly revealed by PAS staining.
In HtrA1-/- placentas, the alignments of blood vessels in the
labyrinth were more random than those in HtrA1þ /þ placentas
(Fig. 2G and I). To gain more detailed insight, placentas were
stained with isolectin B4, which speciﬁcally stains fetal blood
vessels. The fetal vessels of HtrA1þ /þ placentas looked elongated
with long straight segments, and ran parallel to each other toward
the decidua (Fig. 2H), while those of HtrA1 -/- placentas were more
randomly aligned (Fig. 2J).
At E16.5, PAS staining showed that the HtrA1-/- placenta was
still signiﬁcantly smaller than wild type placenta (Fig. 2M and N),
although the difference was less marked than at E14.5 (Fig. 2S,
bottom panel). The area and number of PAS-positive islands in
labyrinth of HtrA1-/- placentas were reduced and not different
Fig. 2. HtrA1-deﬁcient placentas have defects in development of junctional zone and labyrinth. (A-D) HE staining of sections from HtrA1 / (B and D) and wild type
(HtrA1þ /þ) placentas (A and C) at E12.5 (A and B) and E14.5 (C and D). (E and F) PAS staining of sections from E14.5 HtrA1 / (F) and HtrA1þ /þ (E) placentas. Arrows in F
show large PAS-positive islands mislocalized in the labyrinth of an HtrA1 -/- placenta. (G and I) Higher magniﬁcations of boxed areas in E and F showing PAS-positive islands
and structure of blood vessels in the labyrinth of HtrA1 -/- (I) and HtrA1þ /þ (G) placentas. Arrowheads in G and I show PAS-positive islands, and arrows in I show PAS-
negative SpT-like cells associated with an island. (H and J) Isolectin B4 staining of sections from E14.5 HtrA1-/- (J) and wild type (H) placentas, showing the structure of fetal
vessels in the labyrinth. (K and L) Higher magniﬁcations of the junctional zone of (E) and (F), showing PAS-negative SpTs (arrows) and PAS-positive GlyTCs (arrowheads) in
HtrA1-/- (L) and HtrA1þ /þ (K) placentas. (M and N) PAS staining of sections from E16.5 HtrA1-/- (N) and HtrA1þ /þ (M) placentas. (O and Q) Higher magniﬁcations of the
labyrinth of (M) and (N). Abnormal vessel formation in HtrA1-/- labyrinth had mostly disappeared on E16.5. (P and R) Isolectin B4 staining of sections showing the labyrinth of
E16.5 HtrA1-/- (R) and HtrA1þ /þ (P) placentas. Structure of vessels is almost normal in HtrA1-/- placentas. (S and T) Sections represented in A-F and K-N were analyzed
morphometrically. (S) Areas of total placenta, junctional zone (JZ) and labyrinth (Lb) at E12.5, E14.5 and E16.5 of HtrA1-/- and HtrA1þ /þ placentas. (T) Area occupied by SpTs
in the junctional zone (SpT/JZ), area occupied by GlyTCs in the junctional zone (GlyTC/JZ), and area of total PAS-positive trophpblast islands in the labyrinth (PAS/Lb) of E14.5
placentas. Five placentas from each genotype and three different sections from each placenta were analyzed. P values were calculated by Welch's t-test. *¼Po0.05,
**¼Po0.01. Results are presented as meanþSD. DB, decidua basalis; JZ, junctional zone; Lb, labyrinth. Black scale bars¼1000 μm. White scale bars¼50 μm.
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from those of wild type placentas (Fig. 2M and N), while the
random alignment of blood vessels in the HtrA1-/- labyrinth had
mostly disappeared (Fig. 2O-R).
Expression of HtrA1 and HtrA3 in placenta
Both HtrA1 and HtrA3 are expressed most abundantly in the
placenta among adult mouse tissues (Oka et al., 2004; Tocharus et
al., 2004), and their expression patterns have been immunohisto-
logically analyzed (Nie et al. 2005, 2006b). However, since these
proteins are secreted, in situ hybridization is necessary to precisely
identify cells expressing HtrA1 and HtrA3. To understand the
function of HtrA1 in development of the placenta and the possible
compensation for HtrA1 function by HtrA3 in HtrA1-/- placentas,
we re-examined HtrA1 and HtrA3 expression patterns by in situ
hybridization (Fig. 3). We also carried out in situ hybridization
using various probes speciﬁc to trophoblast cell lineages in order
to precisely identify cells that express HtrA1 (Fig. 3A-C).
At E7.5, HtrA1 was expressed strongly by cells in the decidua
capsularis and weakly in the outer layer of the EPC (Fig. 3A),
whereas HtrA3 was very faintly expressed in a small number of
cells in the decidua basalis (data not shown). At E8.5, HtrA1
expression became more prominent in the outer EPC and con-
tinued in the decidua capsularis (Fig. 3D and H). HtrA1 expression
Fig. 3. Expression of HtrA1 and HtrA3 in developing mouse placenta at E7.5, E8.5 and E9.5. In situ hybridization was carried out on serial sections from E7.5 (A and B), E8.5
(D-J) and E9.5 (K-Y) placentas using probes for HtrA1 (A, B, D, H, K, Q and T), HtrA3 (G, P, S and Y), Tpbpa (E, I, L and U), Plf (F, J, M and V), Pl1 (N, R and W) and Pl2 (O and X). HE
staining of a serial section adjacent to B is shown in C. Boxed areas in A and D-F are magniﬁed in B and H-J, respectively. Higher magniﬁcations of the junctional zone (black
boxed area) in K-P are shown in T-Y, respectively. Higher magniﬁcations of the decidua capsularis (white boxed area) in K, N and P are shown in Q, R and S, respectively. The
mesometrial side is at the top and the fetal or anti-mesometrial side is at the bottom. EPC, ectoplacental cone; DB, decidua basalis; DC, decidua capsularis; Emb,embryo.
Dotted lines in B, H, I and J indicate the boundary between the EPC and the maternal decidua. Dotted lines in T-Y indicate the boundary between the junctional zone and the
decidua. Scale bars¼500 μm.
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in the outer EPC was conﬁrmed by in situ hybridization with Tpbpa
and Plf as probes. Tpbpa is a marker of the EPC and is expressed by
progenitors of SpTs (Simmons and Cross. 2005), and Plf is a marker
of secondary TGCs, which are in the outermost layer of the EPC at
this stage (Simmons et al. 2008). HtrA1 expression was observed
in the area where Tpbpa-positive or Plf-positive cells existed
(Fig. 3E, F, I and J). At E9.5, HtrA1 expression was restricted to a
thin outer layer of cells in the junctional zone which zone is
Fig. 3. (continued)
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differentiated from the EPC (Fig. 3K, T). In situ hybridization of
E9.5 placenta with the Tpbpa probe conﬁrmed again that HtrA1
was expressed by trophoblast lineage cells in the junctional zone
(Fig. 3K, L, T and U). The HtrA1-expressing cells (Fig. 3T) were also
positive for other trophoblast cell lineage markers such as Plf and
Pl2 (Fig. 3V and X). Plf-positive trophoblast cells migrating into the
decidua are deﬁned as SpA-TGCs. Therefore, HtrA1-expressing
cells in the decidua near the junctional zone (Fig. 3T) are probably
SpA-TGCs. Primary trophoblast giant cells are the ﬁrst trophoblast
cell lineage; they differentiate at around E6.5 from the mural
trophectoderm, demarcate the border between fetal and maternal
tissues, and express PlI (Fig. 3N, R and W). The HtrA1-expressing
cells in the decidua capsularis (Fig. 3K and Q) were negative for Pl1
(Fig. 3R), indicating that primary TGCs do not express HtrA1. On
the other hand, HtrA3-expressing cells (Fig. 3P, S and Y) were
negative for all these trophoblast markers. HtrA3 expression,
therefore, is restricted to decidual cells.
From E10.5 to E12.5, HtrA1-expressing cells were also detected
inside the decidua basalis, closed to the junctional zone, and some
HtrA1-expressing cells in the decidua basalis were associated with
maternal arteries (Fig. S4B, C, G, and H, arrows). HtrA1 expression
in the decidua capsularis decreased at E10.5 but was still very
strong compared to that in the junctional zone (Fig. S4A). HtrA3
expression gradually increased and was detected diffusely in the
decidual cells in both the basal and capsular regions in this period
(Fig. S4D, E and I). Some HtrA3-expressing cells densely sur-
rounded maternal arteries in the decidua on E10.5 and E12.5
(Fig. S4F and J, arrows).
Tpbpa-positive cells decrease in the junctional zone but increase in
the labyrinth of HtrA1 / placenta
HtrA1-/- placentas showed a remarkable decrease in SpTs and
GlyTCs in the junctional zone at E14.5 (Fig. 2). SpTs and GlyTCs
originate from the same Tpbpa-positive precursors that are present
in the outer layer of the EPC at E8.5. The cells expressing Tpbpa
differentiate into SpTs at around E10.5 and GlyTCs differentiate
from SpTs at around E12.5 (Simmons et al., 2007). Tpbpa expres-
sion continues in SpTs and GlyTCs at E14.5. Since HtrA1-expressing
cells were positive for Tpbpa at E8.5 and E9.5 (Fig. 3H, I, T and U),
we next examined whether the absence of HtrA1 affects Tpbpa-
positive cell lineages. At E10.5, there were fewer Tpbpa-expressing
cells in HtrA1-/- placentas (Fig. 4B and D) than in HtrA1þ /þ
placentas (Fig. 4A and C). This decrease was also observed at later
stages. HtrA1-/- placentas at both E12.5 and E14.5 showed a
decrease in Tpbpa-positive cells in the junctional zone (Fig. 4E-
L). These results strongly suggest that defects in Tpbpa-positive
precursor cells result in the reduction of SpTs and GlyTCs observed
in the junctional zone. PAS-positive trophoblast islands in the
labyrinth, which increased signiﬁcantly in HtrA1-/- placenta at
E14.5, were also positive for Tpbpa (Fig. 4G, H, K and L, arrows).
SpTs and TGCs differentiate from a common precursor in the EPC.
The cell fate decision to differentiate into SpTs is positively
regulated by the transcription factor Mash-2, and Tpbpa-positive
SpTs were absent in Mash-2 KO mice (Guillemot et al., 1994).
Mash-2 expression was detected in both junctional zone and
labyrinth at E10.5 (Fig. 4M-P), as previously reported (Nakayama
Fig. 4. Absence of HtrA1 reduces Tpbpa-positive cells in the junctional zone. In situ hybridization of sections from HtrA1þ /þ (ﬁrst and third columns) and HtrA1-/- (second
and fourth columns) placentas at E10.5 (A-D and M-P), E12.5 (E-H) and E14.5 (I-L) was performed using the Tpbpa probe (A-L) andMash-2 probe (M-P). Boxed areas in A, B, E,
F, I, J, M and N are magniﬁed in C, D, G, H, K, L, O and P, respectively. HtrA1-/- placentas had fewer Tpbpa-positive andMash-2-positive cells in the junctional zone compared to
HtrA1þ /þ placentas. PAS-positive islands in the labyrinth were also Tpbpa-positive (arrows in G, H and L) and increased in HtrA1-/- placentas (F, H, J and L) as compared to
wild type placentas (E, G, I and K). Scale bars¼500 μm.
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et al., 1997).Mash-2-positive cells in HtrA1-/- placentas (Fig. 4N and
P) were reduced compared to HtrA1þ /þ placentas (Fig. 4M and N).
The reduction was more prominent in junctional zone than in
labyrinth (Fig. 4O and P), supporting the idea that SpT differentia-
tion from EPC precursors was defective in HtrA1 / placentas. All
these data indicate that HtrA1 / placentas have abnormalities in
the differentiation of SpTs and GlyTCs from Tpbpa-positive pre-
cursor cells. To reveal whether other trophoblast subtypes were
affected by deletion of the HtrA1 gene, we examined E9.5 placen-
tas from HtrA1 / mice by in situ hybridization with Plf, Pl2 and
Pl1 probes, which are commonly used for trophoblast subtype
identiﬁcation.
SpA-TGCs decrease and maternal artery remodeling is compromised
in the absence of HtrA1
Plf-positive cells are differentiated from Tpbpa-positive cells
and Plf is a marker for secondary P-TGCs, SpA-TGCs, and C-TGCs at
later stages around E12.5 and E14.5. SpA-TGCs invade into the
decidual tissues and associate with maternal arteries (Simmons et
al., 2007). In E9.5 HtrA1 / placentas, fewer Plf-positive cells
invaded into the decidua (Fig. 5C and D) than did so in HtrA1þ /þ
placentas (Fig. 5A and B). Similar defects in invasion and arterial
association of Plf-positive SpA-TGCs were observed in the E12.5
HtrA1/ decidua (Fig. 5I-L). The decrease in SpA-TGCs is clearly
depicted in Fig. 7M, which shows the number of Plf-positive cells
surrounding maternal arteries in HtrA1-/- and wild type placentas
at E9.5. The association of SpA-TGCs with maternal arteries
induces remodeling of the arteries, which results in enlargement
of the arterial cavity to increase blood ﬂow to the fetal placenta
(Adamson et al., 2002). We measured the lumen diameters of
arteries which were associated with Plf-positive cells at E9.5
(Fig. 5N). The data showed that although some SpA-TGCs attached
to maternal arteries in the HtrA1 / placentas, the association was
not enough to induce enlargement of the cavity.
At an early stage, around E9.5, invading SpA-TGCs and some
vessel-associated SpA-TGCs express Tpbpa (Fig. 3U and V; (Mold et
al., 2012)). To conﬁrm the results with Plf, we did performed in situ
hybridization with the Tpbpa probe. Fewer Tpbpa-positive cells
invaded into the decidua and associated with maternal arteries in
the HtrA1 / placentas at E9.5 than in the HtrA1þ /þ placentas
(Fig. 5E-H).
During remodeling, the vessel walls of maternal spiral arteries
become thin and lumen diameters widen. At E12.5, HE staining of
maternal arteries in the distal part of the decidua showed that the
lumen of arteries was narrower, and the walls of arteries were
thicker, in HtrA1 / placentas than in HtrA1þ /þ placentas (Fig. 6A
and B). Another aspect of spiral artery remodeling is the replace-
ment of vascular smooth muscle cells in arterial walls by the
invading trophoblasts. Arteries in the decidua of HtrA1/ pla-
centas had more vascular smooth muscle cells, which were labeled
with anti-smooth muscle α-actin antibody, than those in HtrA1þ /
þ placentas at E 9.5 (Fig. 6C and D). All these observations indicate
that maternal spiral artery remodeling is defective in HtrA1 /
placentas. Consistent with those observations, the ratio of inner
lumen diameter to outer diameter (LD/OD) was reduced in
HtrA1/ arteries at E12.5 and E14.5 (Fig. 6E).
Canal trophoblast giant cells increase in the absence of HtrA1
Pl2 is a lineage marker for C-TGCs and P-TGCs in the junctional
zone and for S-TGCs in the labyrinth (Simmons et al., 2007). Pl2-
positive cells increased markedly in the junctional zone of HtrA1 /
 placentas at E9.5 (Fig. 7A-D) as well as E12.5 (Fig. 7 E-H). The
number of Pl2-positive S-TGCs in the labyrinth did not differ
between HtrA1 / and wild type mice (Fig. 7G and H).
Differentiation of Tpbpa-positive cell lineages is preferentially affected
in HtrA1 / placenta
So far we have described abnormal trophoblast populations in
HtrA1-/- mice; decreased numbers of SpTs and GlyTCs in the
junctional zone and of SpA-TGCs in the decidua, mislocalization
of PAS-positive cells in the labyrinth, and an increase in Pl2-
positive trophoblasts in the junctional zone. A common feature of
these trophoblast cell lineages is that they differentiate from
Tpbpa-positive precursors in the outer EPC (Simmons et al.,
2007). To examine whether only the trophoblasts derived from
Tpbpa-positive precursors were affected in HtrA1-/- placentas, we
conducted in situ hybridization with Pl1 as the probe. Pl1 is a
marker for primary P-TGCs, which originate from both Tpbpa-
positive and -negative precursors. In situ hybridization of E9.5
(Fig. 7I-L) and E10.5 placentas (data not shown) showed that the
number and distribution of Pl1-positive cells in HtrA1-/- placentas
were similar to those in wild type placentas. This result suggests
that Tpbpa-positive cell lineages are preferentially affected by the
loss of HtrA1.
Matrix metalloproteinase (MMP)-9 activity is reduced in
HtrA1 / placenta
HtrA1 digests ﬁbronectin and the digested fragments enhance
the production of MMP-1 and MMP-3 in human synovial ﬁbro-
blasts (Grau et al., 2006). Similarly, ﬁbronectin fragments gener-
ated by α-chymotrypsin enhance the secretion of MMP-3 and
MMP-9 in murine RPE cells (Grau et al., 2006; Austin, et al., 2009).
However, MMP-2 productionwas not affected in either cell type by
ﬁbronectin fragments (Grau et al., 2006; Austin et al., 2009). We
compared MMP activities by gelatin zymography of extracts from
Htr1þ /þ and HtrA1/ placenta at E10.5 (Fig. S5), when the MMP
activities in placenta are highest during pregnancy (Fontana et al.,
2012). Consistent with previous report (Fontana et al., 2012),
MMP-9 and MMP-2 are the major MMPs in the placenta at this
stage. Gelatin zymography indicated that MMP-9 activity was
reduced in HtrA1-/- placentas, but MMP-2 activity was not affected
(Fig. S5B), suggesting that the loss of HtrA1 activity suppressed the
expression or activation of MMP-9. This decrease in MMP9 activity
may compromise the migration of TGCs and the remodeling of
maternal arteries.
Embryonic HtrA1 loss contributes to the abnormal phenotype of
placentas
To determine which HtrA1 deﬁciency, maternal or embryonic,
contributed to the phenotype of the HtrA1 / placenta, placentas
derived from matings between different genotypic combinations
were analyzed (Fig. S6). Placentas of HtrA1/ females crossed
with HtrA1þ /þ males were normal in size (Fig. S6 A-C, J-L and S-T)
and showed normal maternal artery remodeling (Fig. S6M-O). In
these placentas, the development of Tpbpa-positive SpTs and Plf-
positive SpA-TGCs was also normal (Fig. S6 D-I and P-R). These
data suggest that the loss of embryonic HtrA1 was the major cause
of the abnormal development of the HtrA1 / placenta.
Discussion
Our in situ hybridization analysis revealed that HtrA1 is
expressed from E7.5 to E12.5 in two distinct regions: the decidua
capsularis and the outer layer of EPC or the junctional zone (Fig. 4).
The mRNA expression pattern at E7.5 is consistent with the protein
distribution, reported previously (Nie et al., 2005), indicating that
HtrA1 protein travels only a short distance after it is secreted.
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Fig. 5. Defective invasion of SpA-TGCs into the decidua in HtrA1-deﬁcient placenta. (A-L) In situ hybridization of sections from HtrA1þ /þ (left) and HtrA1-/- (right) placentas at E9.5
(A-H) and E12.5 (I-L) were carried out using the Plf probe (A-D and I-L) and the Tpbpa probe (E-H). These probes detect SpA-TGCs in the decidua. Fewer Plf-positive (arrows in B and D)
and Tpbpa-positive (arrows in F and H) cells invade into HtrA1 / decidua than intoHtrA1þ /þ decidua at E9.5. Fewer Plf-positive cells line maternal arteries in HtrA1 / decidua (J and
L) than in wild type decidua (I and K) at E12.5. Dotted lines indicate the boundary between the junctional zone and the maternal decidua. (M) Number of SpA-TGCs that had invaded
into the decidua was counted in HtrA1-/- and wild type placentas. One section which had most Plf-positive cells and ﬁve placentas for each genotype were measured. (N) Lumen
diameter of the SpA-TGC-associated arteries was measured in the decidua of HtrA1/ and HtrA1þ /þ placentas at E9.5. More than ﬁve arteries for one placenta and three placentas for
each genotype were measured. P values were calculated by Welch's T test. **¼Po0.01. Results are presented as meanþSD. Scale bars¼500 μm.
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HtrA1 protein is probably deposited in the ECM of the placenta, as
it is in bone and cartilage (Tsuchiya et al., 2005). HtrA1 mRNA in
the whole placenta is ﬁrst detected at E7.5, reaches its peak at
E10.5, and quickly declines by E12.5 (Nie et al., 2005). This
expression kinetics agrees well with the expression levels in the
decidua capsularis, which is the major source of HtrA1 mRNA
(Fig. 3). A small number of cells in the EPC express HtrA1 at E7.5. At
E8.5, HtrA1 mRNA expression in the EPC is increased in the cells
localized in the outer layer. Those HtrA1-expressing cells also
express Tpbpa and are therefore the precursors of SpTs and GlyTCs.
At E9.5, the HtrA1-expressing cells are restricted to the outermost
layer of the junctional zone, where Tpbpa is also expressed. At later
stages, around E10.5 and E12.5, some HtrA1-expressing cells
invade into the decidua and surround maternal vessels. These
cells ﬁt the deﬁnition of SpA-TGCs; indeed, they overlap with cells
expressing Plf, a marker of SpA-TGCs at this stage. HtrA3 expres-
sion starts one day after HtrA1 expression. At E8.5, HtrA3 expres-
sion is weakly detected in the decidua basalis and the decidua
capsularis, and reaches its peak at E10.5 (Fig. 3). In the decidua
basalis, HtrA3 expression was still high at E12.5 when the expres-
sion of HtrA1 had already decreased. This result is also consistent
with a previous report (Nie et al., 2006b) showing that moderate
HtrA3 expression in the decidua basalis continues until the later
stages of pregnancy. More importantly, HtrA3 expression is
restricted to maternal decidual cells and is not detected in any
type of fetal trophoblast cell. In contrast, HtrA1 is expressed in
Fig. 6. Impaired maternal artery remodeling in HtrA1 / placentas. (A and B) HE staining of a distal part of the decidua of E12.5 HtrA1 / (B) and HtrA1þ /þ (A) placentas.
Dotted lines in A and B indicate the boundary between the decidua and the myometrium. HtrA1þ /þ arteries have dilated lumens and thin walls (asterisks in A). In contrast,
HtrA1-/- arteries have narrow lumens and thick walls (asterisks in B). (C and D) Immunostaining with anti-smooth muscle α-actin antibody of sections from E9.5 HtrA1 /
(D) and HtrA1þ /þ (C) placentas. More vascular smooth muscle cells associate with arteries in the decidua of HtrA1/ placenta (arrows in D) as compared to HtrA1þ /þ
placenta (arrows in C). Dotted lines in C and D show the boundary between the junctional zone and the maternal decidua. (E) Ratio of inner lumen diameter (LD) to outer
diameter (OD) of maternal arteries in the distal part of the decidua of E10.5, E12.5 and E14.5 HtrA1/ and HtrA1þ /þ placentas. More than ﬁve arteries from one placenta and
ﬁve placentas for each genotype were measured at each time point. P values were calculated by Welch's t-test. *¼Po0.05, **¼Po0.01. Results are presented as meanþSD.
Scale bars¼500 μm.
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both maternal cells in the decidua capsularis and fetal tropho-
blasts in the EPC. Collectively, these data show that HtrA1 and
HtrA3 are expressed in a complementary manner, in different cells
and in different periods during development of the mouse
placenta. The HtrA1/ placenta shows the most severe pheno-
types at E14.5, but most abnormalities disappear by E16.5 (Fig. 2).
It is possible that the function of HtrA1 is compensated for by
HtrA3 at the later stages of pregnancy, when HtrA3 is dominant.
Although HtrA1 expression in the decidua capsularis is very high,
no signiﬁcant abnormality was observed in this region throughout
gestation (Fig. S3). Since both HtrA1 and HtrA3 are expressed in
the cells of the decidua capsularis, HtrA3 may compensate the
deﬁciency of HtrA1.
In human placenta, strong HtrA1 expression is detected in
decidual cells in the ﬁrst trimester (Nie et al., 2006a). At this stage,
lower but moderate HtrA1 expression is also observed in tropho-
blasts (Nie et al., 2006a) such as villous cytotrophoblasts (CTBs),
syncytotrophoblasts (STBs) and invasive EVTs. Villous CTBs provide
precursors of all trophoblasts, as do cells in the EPC in mouse
placenta. The existence of analogous progenitor cells in human
and mouse (Fig. 2) expressing HtrA1 indicates an important
function for HtrA1 in the differentiation of trophoblasts. STBs arise
by fusion of differentiated CTBs, and EVTs differentiate from
proliferating CTBs in CTB cell columns, where HtrA1 is expressed
intensively in the ﬁrst trimester (Marzioni et al., 2009). EVTs
invade into the decidua (interstitial EVTs) and associate with
maternal vessels (endovascular EVTs). HtrA1 expression in these
ETVs is thought to be involved in cell invasion and maternal artery
remodeling (Marzioni et al., 2009; Chen et al., 2014), functions
similar to those that are expected for mouse Tpbpa-positive
trophoblasts invading into the decidua and Plf-positive SpA-TGCs,
two types of mouse trophoblasts expressing HtrA1 (Fig. 2).
The placenta of HtrA1-deﬁcient mouse is small due to a
reduction in size of the junctional zone and the labyrinth as well
as an insufﬁciency of vasculogenesis in the labyrinth. These
abnormalities probably cause intrauterine growth retardation.
The principal defect in the HtrA1-/- placenta may be the decrease
in Tpbpa-positive trophoblast precursors in the EPC at an early
stage of placentation. This defect reduces SpT and GlyTC numbers,
resulting in the small junctional zone, which is most prominent at
E14.5. Ablation of Tpbpa-positive precursors by diphtheria toxin
transgene expression results in the reduction of SpTs around E10.5
and of GlyTCs at later stages (Hu and Cross., 2011), in agreement
with our ﬁnding that the reduction of SpTs and GlyTCs is caused by
the loss of Tpbpa-positive precursor cells in the HtrA1-/- placenta.
Although HtrA1 expression is not evident in the labyrinth
throughout gestation, the development of the labyrinth is poor
in the absence of HtrA1, suggesting that secondary mechanisms
induce defects in the labyrinth. Poor development of the labyrinth
has been reported as a secondary consequence of defects in SpTs in
the junctional zone (Guillemot et al., 1995; Tanaka et al., 1997;
Rodriguez et al., 2004; Arima et al., 2006). In the HtrA1 /
Fig. 7. C-TGCs are increased in HtrA1/ placentas on E 9.5. In situ hybridization of sections from E9.5 (A-D and I-L) and E12.5 (E-H) HtrA1/ (right) and HtrA1þ /þ (left)
placentas was carried out using the Pl2 probe, a C-TGC marker (A-H) and the Pl1 probe, a P-TGCs marker (I-L). Higher magniﬁcations of boxed areas in A, C, E, F, I and K are
shown in B, D, G, H, J and L, respectively. JZ, junctional zone; Lb, labyrinth. Scale bars¼500 μm.
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placenta, excessive Tpbpa-positive cells which are either PAS-
positive or -negative remain in the labyrinth at E12.5 and E14.5,
but disappear by E16.5 (Fig. 2). This mislocalization may be caused
by a delay in cell migration to the junctional zone, and thus
contribute to the reduction of GlyTCs and SpTs there. Similar
mislocalization of trophoblasts has been observed previously in
BPH/5 preeclampsia model mice (Dokras et al., 2006), heme
oxigenase-1-deﬁcient mice (Zhao et al., 2009), Cited1-deﬁcient
mice (Rodriguez et al., 2004), and in a mouse model of pregnancy
diabetes (Salbaum et al., 2011); trophoblast mislocalization in
these mice has been explained by aberrant differentiation of SpTs.
These mice mostly show poor development of the labyrinth and
intrauterine growth retardation. Excessive and persistent localiza-
tion of trophoblast islands in the labyrinth may inhibit normal
vessel formation and development of the labyrinth by physical
hindrance. The mislocalized trophoblasts may also secrete factors
such as pro- or anti-angiogenic factors that disturb the develop-
ment of the labyrinth.
SpA-TGCs express HtrA1 and their numbers are reduced in the
HtrA1-/- placenta. A lineage-tracing experiment using Tpbpa-Cre
transgenic mice has revealed that all SpA-TGCs are derived from
Tpbpa-positive precursors (Simmons et al., 2007). Diphtheria toxin-
mediated ablation of Tpbpa-positive cells also led to a decrease in
Plf-positive SpA-TGC number and insufﬁcient maternal artery remo-
deling (Hu and Cross, 2011). Plf-positive SpA-TGCs migrate into the
decidua, where they replace smooth muscle and endothelial cells of
the maternal spiral artery. This remodeling of the artery enlarges the
lumen diameter and increases blood ﬂow to the fetal placenta, and is
one of the most important mechanisms to prevent PE. We showed
that the diameter of the spiral artery is narrower, and the arterial
wall is thicker and contains more smooth muscle cells, in HtrA1-/-
placenta than in HtrA1þ /þ placenta. These phenotypes represent
compromised arterial remodeling and are probably caused by the
reduction in migrating SpA-TGCs. In the remodeling process, pro-
tease activity is required to digest ECM proteins surrounding arteries
(Harris and Aplin, 2007; Palei et al., 2013). Since HtrA1 effectively
degrades ECM proteins such as ﬁbronectin, decorin, biglycan, and
collagens in vitro (Tsuchiya et al., 2005; Grau et al., 2006), HtrA1
secreted from SpA-TGCs may digest ECM proteins and accelerate the
invasion of SpA-TGCs into the decidua and their arrival at maternal
arteries. Degradation of elastic ﬁbers in arterial walls is another
essential step in artery remodeling (Harris and Aplin, 2007; Harris
et al., 2010). Mice overexpressing HtrA1 in the retina show damage
in the basement membrane of the pigment epithelium and elastic
ﬁbers of choroid blood vessels (Jones et al., 2011; Vierkotten et al.,
2011), attributed to an elastase activity or a proteolytic activity
toward ﬁbulin 5, an essential factor of elestogenesis, of HtrA1. Some
HtrA3-expressing cells in the decidua are densely associated with
maternal arteries (Fig. S4), and they may contribute to remodeling of
the spiral arteries.
Collectively, the defective development of the labyrinth and the
junctional zone, impaired arterial remodeling, and intrauterine
growth retardation found in HtrA-/- mice may be a consequence of
abnormal differentiation of SpTs, GlyTCs and SpA-TGCs from
Tpbpa-positive precursors.
Tpbpa-positive lineage cells appear to be preferentially affected
in the HtrA1-/- placenta. Pl1-positive primary P-TGCs, which
originate not only from Tpbpa-positive precursors but also from
Tpbpa-negative cells, are not affected (Fig. 7); Pl2-positive cells,
which also differentiate from both Tpbpa-positive and Tpbpa-
negative cells (Simmons et al., 2007), are increased at E9.5 and
E12.5 in the HtrA1/ placenta (Fig. 7). Compensatory mechan-
isms presumably stimulate differentiation of Pl2-positive cells
from Tpbpa-negative precursors.
The molecular mechanisms underlying the differentiation of
various trophoblasts from trophoblast stem (TS) cells are not well
characterized. Differentiation of mouse TS cells is known to be
regulated by FGF 4 and TGF-β (Tanaka et al., 1998; Erlebacher et al.,
2004). HtrA1 is an inhibitor of TGF-β signaling (Oka et al., 2004;
Hara et al., 2009); its expression is induced by FGF during Xenopus
and chicken development (Hou et al., 2007; Ferrer-Vaquer et al.,
2008), and HtrA1 positively regulates FGF signaling in Xenopus
(Hou et al., 2007). Loss of HtrA1 in TS cells might affect cell fate
determination through modiﬁcation of TGF-β and/or FGF signal-
ing. At E7.5, HtrA1 expression began in the EPC, which consists of
progenitors of both secondary TGCs and SpTs. Loss of this early
expression of HtrA1 in the EPC might affect the cell lineage
determination and result in a decrease of Tpbpa-positive SpTs
and an increase of Pl2-positive TGCs. Several soluble factors such
as retinoic acid (Yan et al., 2001) and parathyroid hormone related
protein (PTHrP) (El-Hashash et al., 2005) are known to stimulate
the differentiation of EPC progenitors into TGCs at the expense of
SpTs. PTHrP expression is also reportedly induced by TGF-β in
primary TGCs (Nowak et al., 1999). HtrA1 may therefore suppress
PTHrP by inhibiting TGF-β signaling. The role of HtrA1 during cell
lineage commitment was reported in human bone marrow-
derived mesenchymal stem cells, in which HtrA1 enhances osteo-
genesis but suppresses adipogenesis (Tiaden et al., 2012).
This study provides evidence that HtrA1 regulates trophoblast
differentiation and maternal artery remodeling. Lack of artery
remodeling due to poor invasion of trophoblasts into the decidua
is one of the major pathophysiological mechanisms underlying the
onset of PE. The placenta of HtrA1-/- mouse shows histological
abnormalities very similar to those in BPH/5 preeclampsia model
mice (Dokras et al., 2006). MMP-9 null mice show abnormalities in
trophoblast differentiation and invasion, and mimic phenotypes of
PE (Plaks et al., 2013). Fragments of HtrA1-digested ﬁbronectin
induce MMP-1 and MMP-3 production in human synovial ﬁbro-
blasts (Grau et al., 2006). In murine RPE cells, ﬁbronectin frag-
ments produced by α-chymotrypsin digestion also enhance MMP-
9 secretion (Austin et al., 2009). We showed that the HtrA1 /
placenta has low MMP-9 activity (Fig. S5), which may be another
factor that leads to its histological abnormalities.
More importantly, our data shed light into the debate on the
role of HtrA1 in PE. Although there are several reports showing
abnormal elevation of HtrA1 in PE, there is no clear evidence yet
whether this is a cause of PE or an outcome of a stress response
imposed by PE. In addition, HtrA1 expression is frequently
decreased in the sera and placentas of PE patients. Our study
supports the idea that HtrA1 has important roles in placental
development in the early stage of pregnancy, and insufﬁcient
HtrA1 expression may cause poor placentation that is depicted by
histological abnormalities very similar to those found in the
placenta of the PE mouse model. Abnormal phenotypes of the
HtrA1 / placenta are mostly accounted for by the embryonic loss
of HtrA1 (Fig. S6). HtrA3 in the decidua may compensate for
functions of maternal HtrA1. Preliminary data indicate that the
double knockout (HtrA1 /; HtrA3/) placenta shows similar but
more severe phenotypes than the HtrA1/- placenta; in addition,
pregnant HtrA1/; HtrA3 / mice display mild hypertension at
the later gestation stage, an effect which was not clearly observed
in pregnant HtrA1 / mice (M.Z.H., unpublished data).
HtrA proteases in general are stress-responsive factors
(Skorko-Glonek et al., 1999; Alba and Gross., 2004; Clausen et
al., 2011). HtrA1 is induced by several types of stress such as
oxidative stress, UV irradiation, and endoplasmic reticulum stress
(Zurawa-Janicka et al., 2008; Ng et al., 2011; Supanji et al., 2013).
We have shown that, in mouse embryonic ﬁbroblasts and retinal
pigment epithelial cells, oxidative stress-induced HtrA1 confers
resistance to cell death but enhances cell senescence (Supanji et
al., 2013). HtrA3 is known to be induced by hypoxia in human
trophoblast cells (Li et al., 2011), and our preliminary data
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indicate that HtrA1 is also induced by hypoxia in mouse embryo-
nic ﬁbroblasts. In early stages of pregnancy, HtrA1 and HtrA3 may
be required for the survival and proper differentiation of placen-
tal cells under hypoxic conditions. In PE, HtrA1 and HtrA3
expression may remain high through mid-gestation, because of
persistent hypoxia. Alternatively, oxidative stress caused by
hypoxia-reperfusion insult may induce expression of the HtrA
proteases in PE patients. Further analysis is needed to elucidate
the precise behavior of HtrA proteases in PE.
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